Co-founded in 2021 by two tech entrepreneurs, Céline Lazorthes and Jonathan Benhamou, and the Gustave Roussy Institute, the 5th largest cancer center in the world, Resilience's mission is to reinvent the way we treat cancer through digital and remote medical monitoring. By deploying its CE-marked medical devices (Class IIa) and its application dedicated to patient well-being, Resilience intends to accelerate the use of remote monitoring between patients and healthcare institutions. This will improve quality of life and increase overall survival, but will also strengthen the link with healthcare professionals. Resilience is supported by international investment funds (including Cathay Innovation and Singular) and a consortium of healthcare players: Fondation Santé Service, MACSF, Ramsay Santé, and Vivalto Ventures. It benefits from a leading scientific advisory board, including Ethan Basch, a world-renowned oncologist and researcher and Director of Research at the University of North Carolina.